US4235865A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for the determination of unbound hormones and pharmaceuticals
Assignee: Chandon Investment Planning Ltd
•
Filing: 1978-04-24
•
Granted: 1980-11-25
•
Expires: 1998-04-24
Abstract
Abstract Disclosed is a method for the determination of unbound hormones and pharmaceuticals comprising placing a solution containing unbound hormones, hormones bound to bonding proteins and bonding proteins into contact with an immobilized antibody; reacting the unbound hormone with the antibody; eluting the hormones bound to bonding proteins and the bonding hormones with a solution containing a marked hormone; reacting the marked hormone with the antibody; eluting the marked hormone not reacted with the antibody, and determining the marked hormone by radioimmunological evaluation.
Inventors
- 👤 Hans A. Thoma
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 00:00
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/74; G01N33/743; Y; Y10; Y10S; Y10S436/00; Y10S436/815; Y10S436/817
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
78 words
A method for the determination of unbound hormones and pharmaceuticals comprising placing a solution containing unbound hormones, hormones bound to bonding proteins and bonding proteins into contact with a dry gel containing immobilized antibody; swelling the gel and reacting the unbound hormone with the antibody; eluting the hormones bound to bonding proteins and the bonding hormones; adding a solution containing a marked hormone; reacting the marked hormone with the antibody, and determining the marked hormone by radioimmunological evaluation.
Claim 2
Independent Claim
78 words
A method for the determination of unbound hormones and pharmaceuticals comprising placing a solution containing unbound hormones, hormones bound to bonding proteins and bonding proteins into contact with a dry gel containing immobilized antibody; swelling the gel and reacting the unbound hormone with the antibody; eluting the hormones bound to bonding proteins and the bonding hormones; adding a solution containing a marked hormone; reacting the marked hormone with the antibody, and determining the marked hormone by radioimmunological evaluation.
Claim 3
Dependent Claim
14 words
The method of claim 1, wherein the antibody is enclosed in a polymer gel.
Claim 4
Dependent Claim
19 words
The method of claim 1 or 2, wherein the antibody is enclosed in an acrylamide polymer or acrylamide copolymer.
Claim 5
Dependent Claim
19 words
The method of claim 1, wherein the swelling takes place for a period of at least about one minute.
Claim 6
Dependent Claim
24 words
The method of claim 2, wherein the eluting solution and marked hormone are maintained separate from each other until addition to the polymer gel.
Claim 7
Dependent Claim
21 words
The method of claim 5, wherein the reacting of the marked hormone takes place for a period of about 10 minutes.
Claim 8
Dependent Claim
63 words
The method of claim 2, wherein the determining by radioimmunological evaluation comprises accurately measuring the amount of marked hormone employed, measuring the amount of marked hormone in the elute; separately measuring the amount of marked hormone in the polymer gel and comparing the measured values with a calibration curve obtained simultaneously by subjecting known concentrations of hormones without protein to the same steps.
Claim 9
Dependent Claim
17 words
The method of claim 1, wherein the temperature is maintained between about -5° C. and 5° C.
Claim 10
Dependent Claim
29 words
The method of claim 1, wherein the unbound hormones and pharmaceuticals determined are selected from the group consisting of thyroid hormones, steroid hormones, glycosides, vitamins, anticoagulants, analgesics and salycilates.
Claim 11
Dependent Claim
32 words
The method of claim 1, wherein the antibody is immobilized in a matrix selected from the group consisting of agar, cellulose, glass particles, polyamides, polyacrylamides and copolymers of acrylamide and copolymerizable monomers.
Claim 12
Dependent Claim
21 words
The method of claim 10 wherein the matrix has a pore size of from about 7 A to about 10 A.
Claim 13
Dependent Claim
13 words
The method of claim 1, wherein the marked hormone is a radiolabled hormone.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-11-25 | 1984-05-26 | 1984-11-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-11-25 | 1988-05-26 | 1988-11-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-11-25 | 1992-05-26 | 1992-11-25 | $7700.00 | Window Closed / Lapsed |